Patents by Inventor Deh-Ming Chang

Deh-Ming Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9162993
    Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II and the synthesis and the application thereof.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: October 20, 2015
    Assignee: National Defense Medical Center
    Inventors: Deh-Ming Chang, Hsu-Shan Huang, Chia-Chung Lee, Chun-Liang Chen
  • Publication number: 20150191438
    Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II and the synthesis and the application thereof.
    Type: Application
    Filed: January 29, 2015
    Publication date: July 9, 2015
    Inventors: Deh-Ming Chang, Hsu-Shan Huang, Chia-Chung Lee, Chun-Liang Chen
  • Patent number: 9018203
    Abstract: The present invention provides a pharmaceutical composition of salicylanilide-derived small molecules include: (a) a compound which structure is selected from formula I or formula II: (b) a pharmaceutically acceptable salt and excipient. The present invention also provides the synthesis method of the pharmaceutical composition and the application thereof.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: April 28, 2015
    Assignee: National Defense Medical Center
    Inventors: Deh-Ming Chang, Hsu-Shan Huang, Chun-Liang Chen, Chia-Chung Lee
  • Patent number: 8975255
    Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II: and the synthesis and the application thereof.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: March 10, 2015
    Assignee: National Defense Medical Center
    Inventors: Deh-Ming Chang, Hsu-Shan Huang, Chia-Chung Lee, Chun-Liang Chen
  • Patent number: 8772344
    Abstract: A pharmaceutical composition for inhibiting osteoclast growth is disclosed in the present invention. The pharmaceutical composition includes a compound represented by a formula (I), and a pharmaceutically acceptable salt and carrier: wherein R1, R2, R3, R4 can be one selected from a group consisting of hydrogen, halogen, C1˜C10 alkyl group, C2˜C10 alkynyl group, amino group, haloalkyl group and sulfonamide group.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: July 8, 2014
    Assignee: National Defense Medical Center
    Inventors: Deh-Ming Chang, Hsu-Shan Huang
  • Publication number: 20130281444
    Abstract: The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II: and the synthesis and the application thereof.
    Type: Application
    Filed: August 9, 2012
    Publication date: October 24, 2013
    Inventors: Deh-Ming CHANG, Hsu-Shan HUNAG, Chia-Chung LEE, Chun-Liang CHEN
  • Publication number: 20130281412
    Abstract: The present invention provides a pharmaceutical composition of salicylanilide-derived small molecules include: (a) a compound which structure is selected from formula I or formula II: (b) a pharmaceutically acceptable salt and excipient. The present invention also provides the synthesis method of the pharmaceutical composition and the application thereof.
    Type: Application
    Filed: September 11, 2012
    Publication date: October 24, 2013
    Inventors: Deh-Ming CHANG, Hsu-Shan Huang, Chun-Liang Chen, Chia-Chung Lee
  • Publication number: 20120232105
    Abstract: A pharmaceutical composition for inhibiting osteoclast growth is disclosed in the present invention. The pharmaceutical composition includes a compound represented by a formula (I), and a pharmaceutically acceptable salt and carrier: wherein R1, R2, R3, R4 can be one selected from a group consisting of hydrogen, halogen, C1?C10 alkyl group, C2?C10 alkynyl group, amino group, haloalkyl group and sulfonamide group.
    Type: Application
    Filed: July 11, 2011
    Publication date: September 13, 2012
    Applicant: NATIONAL DEFENSE MEDICAL CENTER
    Inventors: Deh-Ming CHANG, Hsu-Shan Huang
  • Publication number: 20050014734
    Abstract: Methods of modulating IL-10 levels in a subject through administration of DHEA are provided herein, as are methods of prophylactically and therapeutically treating medical conditions in a subject through modulating the subject's level of IL-10 with administration of DHEA.
    Type: Application
    Filed: July 18, 2003
    Publication date: January 20, 2005
    Applicant: Genovate Biotechnology Co., Ltd.
    Inventor: Deh-Ming Chang